
Abrocitinib shows efficiency for atopic dermatitis treatment
According to results presented at the European Academy of Dermatology and Venereology virtual congress, patients with moderate to severe atopic dermatitis had a greater improvement with abrocitinib 100mg or 200mg than with placebo.









